SLC6A4 and Parkinson disease: An overall decrease of the 5-HT transporter SERT binding levels is detected in orbitofrontal cortex, caudate, putamen and midbrain of clinically advanced, non-depressed PD patients [10], albeit higher degree of impairment seems to occur in severe parkinsonism or Lewi Bodies Disorders [11].